Clinical Observation on the Treatment of Acne Vulgaris with Different Frequencies of Auricular Point Pricking Combined with Auricular plaster therapy

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ITMCTR

Registry ID

ITMCTR1900002669

Enrollment

Unknown

Registered

2019-10-14

Start date

2020-01-01

Completion date

Unknown

Last updated

2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acne vulgaris

Interventions

Experimental group:Bloodletting at auricular points combined with Auricular plaster therapy, two times a week, four weeks as a course of treatment, three courses of treatment

control group 1:Bloodletting at auricular points combined with Auricular plaster therapy, once a week, four weeks as a course of treatment, three courses of treatment

control group 2:Bloodletting at auricular points combined with Auricular plaster therapy, three times a week, four weeks as a course of treatment, three courses of treatment.

Eligibility

Sex/Gender

All

Age

15 Years to 35 Years

Inclusion criteria

Inclusion criteria: (1) It conforms to the diagnostic criteria of acne vulgaris; (2) GAGS score was 19-38 (moderate and severe); (3) The age is 15-35 years old;

Exclusion criteria

Exclusion criteria: (1) Other types of acne: aggregate acne, fulminant acne, medicinal acne, premenstrual acne, cosmetic acne, occupational acne; (2) Patients with other diseases that may affect the severity of acne, such as polycystic ovary syndrome, thyroid disease, atypical congenital adrenal hyperplasia, or use other drugs to treat systemic diseases; (3) Patients who have used antibiotics for local or systemic treatment in the past six weeks, patients who have used retinoic acid drugs for systematic treatment in the past nine months, patients who have used steroids for systematic treatment in the past nine months, or those who have used contraceptives or anti-inflammatory drugs in the past three months; (4) At present, other skin diseases, such as rosacea and folliculitis, which may interfere with acne evaluation, are being combined. (5) Patients suffering from serious heart, liver, kidney, hematopoietic system diseases and general malnutrition; (6) Pregnant or lactating women; (7) Patients who have been treated with this study regimen in the past 30 days.

Design outcomes

Primary

Measure	Time frame
Skin lesion score;Martin developed a facial acne specific quality of life scale;	—

Secondary

Measure	Time frame
Zung-Self-rating Depression Scale;Zung-Self-rating Anxiety Scale;	—

Countries

Hebei

Contacts

Public ContactYanfen She

Hebei College of Traditional Chinese Medicine

sheyanfen@163.com+86 15833955088

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026